Kristina S Yu

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Positron Emission Tomography

Hodgkin Lymphoma

Top Venues

JCO oncology practice

Future oncology (London, England)

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Susan K Parsons, Kristina S Yu, Nicholas Liu, Supriya Kumar, Michelle A Fanale, Katie Holmes, Carlos Flores Avile, Andy Surinach, Darcy R Flora, Andrew M Evens
Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography-Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study. JCO oncology practice (2023)
Christopher Yasenchak, Nicholas Liu, April Beeks, Michelle A Fanale, Nicholas J Robert, Ding He, Kristina S Yu
Real-World Use of Positron Emission Tomography-Computed Tomography and Reported Deauville Scores in Advanced-Stage Classic Hodgkin Lymphoma: A Community Oncology Practice Perspective. JCO oncology practice (2023)
David Elsea, Kerry J Savage, Cameron Lilley, Julie Lisano, Jingmin Liu, Kristina S Yu
Cost-Effectiveness of Brentuximab Vedotin Versus Physician's Choice of Methotrexate or Bexarotene for the Treatment of Cutaneous T-cell Lymphoma in Canada. Advances in therapy (2023)
John M Burke, Nicholas Liu, Kristina S Yu, Michelle A Fanale, Andy Surinach, Carlos Flores Avile, Julie Lisano, Tycel Jovelle Phillips
Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy. The oncologist (2023)
Andrew M Evens, Kristina S Yu, Nicholas Liu, Andy Surinach, Katherine Holmes, Carlos Flores Avile, Michelle A Fanale, Darcy R Flora, Susan K Parsons
Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study. Future oncology (London, England) (2023)